Stay updated on Biogen Press Releases

Sign up to get notified when there's something new on the Biogen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Biogen Press Releases page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new Biogen news item appears on the page: 'Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options' dated January 28, 2026.
    Difference
    0.8%
    Check dated 2026-02-04T05:12:16.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A new news release item was added to the News Releases page announcing FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review (January 25, 2026).
    Difference
    0.8%
    Check dated 2026-01-28T03:32:21.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added two Biogen News releases: the Q4 and full-year 2025 financial results announcement (February 6, 2026) and the European Commission approval of a high-dose Spinraza regimen for SMA (January 12, 2026).
    Difference
    2%
    Check dated 2026-01-14T01:44:19.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    New 2026 news entries were added, including Biogen to Present at the 44th Annual J.P. Morgan Healthcare Conference and the LEQEMBI submission accepted in China, along with a 2026 copyright line, while older 2025 items were removed.
    Difference
    8%
    Check dated 2026-01-07T01:22:21.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Two new items were added to Biogen News on December 22, 2025: 'Biogen Issues Statement in Response to the Passing of Charles Weissmann, MD, Ph.D., Co-Founder of Biogen' and 'The Journal of the American Medical Association (JAMA) Neurology Publishes Long Term Results from the QALSODY Phase 3 VALOR Study and its Open-Label Extension in SOD1-ALS'. Two November 2025 items were removed: 'Biogen to Highlight New Lecanemab Data and Scientific Advances at the 18th Clinical Trials on Alzheimer’s Disease Conference' and 'Biogen to Participate in Upcoming Investor Conferences'.
    Difference
    4%
    Check dated 2025-12-23T17:24:45.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The News page adds four December 2025 press releases and removes three older items from the listing.
    Difference
    4%
    Check dated 2025-12-09T01:24:00.000Z thumbnail image

Stay in the know with updates to Biogen Press Releases

Enter your email address, and we'll notify you when there's something new on the Biogen Press Releases page.